Institutional Sign In

Go

Saneca Pharmaceuticals - Indebtedness

Net Debt/EBITDA & Net Debt/Equity
Pharmaceutical | Slovakia | November 24, 2020
$2.99
Excel Sheet

Saneca Pharmaceuticals's net debt stood at EUR 8.68 mil and accounted for 35.7% of equity at the end of 2019. The ratio is up 46.7 pp compared to the previous year.

Historically, the firm’s net debt to equity reached a high of 35.7% in 2019 and a low of -11.0% in 2018 between 2018 and 2019. The average for the last five years was 12.3%.

Net debt to EBITDA was calculated at -5.20x at the end of the year. That is down from x seen in 2014. The ratio reached a high of -1.52x in 2018 and a low of -5.20x in 2019.

The company’s cost of funding amounted to in 2019,

A PHP Error was encountered

Severity: Warning

Message: Division by zero

Filename: models/Chunks_model.php

Line Number: 515

up which is above the 5-year of nan%. Funding costs have “eaten” some 0% of the operating profit generated in 2019.

You can see all the company’s data at Saneca Pharmaceuticals profile, or you can download a report on the company in the report section.

Net Debt/EBITDA Unit 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Chirana T. Injecta Group ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 0.539 0.991 2.07 2.72 2.14
Saneca Pharmaceuticals ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
AVERAGE ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 1.85 1.45 1.28 0.883 0.539 0.991 2.07 2.72 2.14 0.149 -1.42 4.99 5.80 2.19 1.08 0.732 0.329

Related Indicators